Final AER Guidance Requires Full Address, Recommends Prefatory Language
This article was originally published in The Tan Sheet
Executive Summary
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs